paclitaxel has been researched along with Cancer of Jejunum in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubo, S; Tomita, N; Yamano, T | 1 |
| Amano, H; Fukuda, T; Kawashima, M; Nakahara, M; Noriyuki, T; Ono, N; Saito, R; Sasada, T; Takei, D; Takemoto, Y; Yamaki, M; Yoshida, M | 1 |
| Fauvet, R; Gondry, J; Merviel, P; Mychaluk, J; Piprot, C; Sevestre, H | 1 |
| Cornelison, TL; Goldberg, JM; Piver, MS | 1 |
4 other study(ies) available for paclitaxel and Cancer of Jejunum
| Article | Year |
|---|---|
A patient-derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Evaluation, Preclinical; Female; Fluorouracil; Gemcitabine; Heterografts; HT29 Cells; Humans; Inhibitory Concentration 50; Irinotecan; Jejunal Neoplasms; Leucovorin; Liver Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Treatment Failure; Trifluridine; Xenograft Model Antitumor Assays | 2020 |
[A Case of Long-Term Survival in a Patient with Small Intestinal Adenocarcinoma with Peritoneal Dissemination].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Floxuridine; Humans; Intestinal Obstruction; Jejunal Neoplasms; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Time Factors | 2016 |
[Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Ileal Neoplasms; Intestinal Perforation; Jejunal Neoplasms; Middle Aged; Paclitaxel | 2009 |
Taxol and platinum chemotherapy in the treatment of pancreatic and jejunal carcinoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Humans; Jejunal Neoplasms; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms | 1995 |